肾小管功能障碍完全解释1A型假性甲状旁腺功能减退症的血浆生化异常
本文报告一例7岁女性1A型假性甲状旁腺功能减退症(PHP-1A)患者,合并双侧肾发育不良并缓慢进展至终末期肾病,16岁接受肾移植。移植后钙、磷及PTH水平迅速正常化,维生素D补充得以停用。这是首例PHP-1A患者接受肾移植的报道,提示肾小管对PTH抵抗足以解释PHP-1A中观察到的钙磷异常。
要点
- PHP-1A患者肾移植后钙磷及PTH水平迅速正常化
- 肾小管对PTH抵抗足以解释PHP-1A的钙磷异常
- PHP-1A患者可合并肾发育不良并进展至终末期肾病
核心结论
- 肾移植后生化参数正常化表明肾小管对PTH抵抗足以解释PHP-1A中观察到的钙磷异常。
研究设计与样本
- 病例报告:一例7岁女性PHP-1A患者,合并双侧肾发育不良并缓慢进展至终末期肾病,16岁接受肾移植。
主要发现
- 患者7岁时表现为PTH抵抗征象(低钙血症、高磷血症和高血清PTH水平),并伴有甲状腺功能减退、早发性肥胖、短掌骨和多次皮下骨化。
- 患者合并双侧肾发育不良,缓慢进展至终末期肾病,16岁接受肾移植。
- 肾移植后钙、磷和PTH水平迅速正常化,得以停用维生素D补充。
临床怎么用
- PHP-1A患者出现肾功能异常时应评估肾发育不良可能。
- 肾移植可纠正PHP-1A患者的钙磷及PTH异常,术后可考虑停用维生素D补充。
局限性
- 本文为单例病例报告,结论需更多病例验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Type 1A pseudohypoparathyroidism (PHP-1A) is characterized by target organ resistance to PTH. Patients can present with various dysmorphic features; however, renal failure has not been classically described. CASE DESCRIPTION: A female patient came to our attention at the age of 7 years with characteristic signs of PTH resistance (i.e., hypocalcemia, hyperphosphatemia, and high serum PTH levels). She also presented with hypothyroidism, early-onset obesity, short metacarpal bones, and multiple subcutaneous ossifications, leading to a clinical diagnosis of pseudohypoparathyroidism. In addition to her genetic condition, she had bilateral renal hypodysplasia that was slowly progressing to end-stage kidney disease. She received a kidney transplant at the age of 16 years and, after transplantation, experienced rapidly normalized calcium, phosphate, and PTH levels, allowing f withdrawal of vitamin D supplementation. CONCLUSIONS: To the best of our knowledge, ours is the first report of a patient with PHP-1A undergoing kidney transplantation. Normalization of biochemical parameters after the procedure demonstrated that renal tubular resistance to PTH is sufficient to explain the calcium/phosphate abnormalities observed in PHP-1A.
引用
- Labbadia R, Bizzarri C, Mucciolo M, et al. Renal Tubular Dysfunction Fully Accounts for Plasma Biochemical Abnormalities in Type 1A Pseudohypoparathyroidism. J Clin Endocrinol Metab. 2019. PMID: 30418563. doi:10.1210/jc.2018-01193
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。